Corticosteroids are any steroid hormones made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Corticosteroids have many different effects in the body, and are used to treat many different conditions. They may be used as hormone replacement, to suppress the immune system, and to treat some side effects of cancer and its treatment. Corticosteroids are also used to treat certain lymphomas and lymphoid leukemias.
Governments in several countries with public Pharmacare and in a few provinces in Canada are considering reclassifying some drugs from prescription to over-the-counter status. In a Canadian Medical Association Journal essay, Lynd and colleagues comment on the economic effects of such changes.
For those people who suffer from eczema, the use of topical corticosteroids is high up on their list of concerns: How should they be used? And are they safe?
The September/October issue of Archives of Facial Plastic Surgery contains several articles on the current state of knowledge and experience with vascular birthmarks, which are caused by blood vessels that do not form correctly.
Better management of asthma in the community is not only possible, but has the potential to reduce the impact of the disease on people’s lives, according to a report by the Australian Centre for Asthma Monitoring (ACAM) , a collaborating unit of the Australian Institute of Health and Welfare.
In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.
In this week's Lancet, Patchell's UK research team evaluate traditional surgical and radiation therapy options and conclude that direct decompressive surgery plus postoperative radiotherapy is more effective than either radiotherapy alone or other surgical options.
A Mayo Clinic study demonstrates that only those multiple sclerosis (MS) patients with evidence for antibody deposition or complement activation -- immune cells that can cause tissue destruction -- in their lesions are likely to respond to plasma exchange, a treatment for acute MS attacks.
An asthma medicine widely used around the world to stop children's coughs has no provable benefit for that purpose and may cause harm, a new review of existing studies reports.
Vascular anomalies - birthmarks caused by abnormal development of arteries, capillaries, veins or lymph vessels - can sometimes begin to progress, requiring aggressive treatment to save the child's health or vision. Research at Children's Hospital Boston now suggests that urine testing can help monitor these anomalies and predict those about to become a serious threat.
A new study shows that a drug, called daclizumab, is effective at reducing organ rejection and risk of infection in heart transplant patients. The multi-center study by cardiologists from the United States, Sweden, Germany and Canada will be published in the June 30 issue of The New England Journal of Medicine.
Although the quality of outpatient care in the United States has improved over the last decade, greater use of evidence-based medicine is needed, however, and quality of care is not significantly associated with the patient's racial or ethnic background, according to a study in the June 27 issue of Archives of Internal Medicine.
La Jolla Pharmaceutical Company today announced that it has received "fast track" designation for Riquent (abetimus sodium) for the treatment of lupus renal disease from the U.S. Food and Drug Administration (FDA).
At a fatal accident inquiry a sheriff has hit out at the "complacency" of health professionals and a drugs manufacturer over the safety of an asthma inhaler steroid.
Corticosteroids should not be used in the treatment of head injuries, conclude the final results of a randomised trial published online today (Thursday May 26, 2005) by The Lancet.
A new asthma treatment regimen promises to deliver a great improvement in key measures of asthma control and should simplify the management of the disease compared with other treatments.
A new inhaled drug for chronic asthma may improve lung function as much as two older inhaled asthma drugs but at half the dose, a review of recent studies concludes.
Decision Resources, a research and advisory firms focusing on pharmaceutical and health care issues, forecasts that sales of asthma therapies in the United States, Japan, and Western Europe will jump from $8.4 billion in 2003 to $13.1 billion in 2013.
According to a study published in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, a nutritionally complete oral supplement enriched with fish oil, soluble fiber and antioxidants reduces reliance on traditional therapies for people with ulcerative colitis.
More than 5,000 people die from asthma each year in the United States. Although asthma deaths are infrequent, they have increased significantly during the last two decades.
New data indicated that earlier intervention with once-daily budesonide, an inhaled corticosteroid delivered by dry powder inhaler to children with mild persistent asthma, significantly reduced the long-term risk and frequency of severe asthma-related events as well as the need for other inhaled medication.